Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher
Yenn‐Jiang Lin(National Yang Ming Chiao Tung University), Shih‐Ann Chen(National Yang Ming Chiao Tung University), Yun‐Yu Chen(National Chung Hsing University), Pai‐Feng Hsu(National Yang Ming Chiao Tung University), Yu‐Feng Hu(Albert Einstein College of Medicine), Li‐Wei Lo(National Yang Ming Chiao Tung University), Shao‐Yuan Chuang(Institute of Biomedical Sciences, Academia Sinica), Cheng-Hung Li(National Yang Ming Chiao Tung University), Hsuan-Ming Tsao(National Yang Ming Chiao Tung University), Ming-Hsiung Hsieh(Wan Fang Hospital), Tsu-Juey Wu(National Yang Ming Chiao Tung University), Tze‐Fan Chao(National Yang Ming Chiao Tung University), Fa‐Po Chung(L-3 Communications (United States)), Chern-En Chiang(National Yang Ming Chiao Tung University), Shih‐Lin Chang(National Yang Ming Chiao Tung University)
Cited by 69
Related Papers
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
|Journal of Arrhythmia|2017|705
Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality?
|Journal of Hypertension|2009|431
Wave Reflection and Arterial Stiffness in the Prediction of 15-Year All-Cause and Cardiovascular Mortalities
|Hypertension|2010|373
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?
|Journal of the American College of Cardiology|2015|258